National Health Determination under paragraph 98C(1)(b) Amendment 2019 (No. 1) (PB 11 of 2019) (Cth)
PB 11 of 2019
National Health Determination under paragraph 98C(1)(b) Amendment 2019 (No. 1)
National Health Act 1953
___________________________________________________________________________
I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
Dated 26 February 2019
THEA DANIEL
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
___________________________________________________________________________
Name of Instrument
(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2019 (No. 1).
(2)This Instrument may also be cited as PB 11 of 2019.
Commencement
This Instrument commences on 1 March 2019.
Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1 Amendments
Schedule 4, entry for Hypromellose
insert as first entry:
| Eye drops 3 mg per mL, 10 mL |
Schedule 4, after entry for Varenicline in the form Box containing 11 tablets 0.5 mg (as tartrate) and 14 tablets 1 mg (as tartrate) in the first pack and 28 tablets 1 mg (as tartrate) in the second pack
insert:
| Venetoclax | Pack containing 14 tablets venetoclax 10 mg and 7 tablets venetoclax 50 mg and 7 tablets venetoclax 100 mg and 14 tablets venetoclax 100 mg |
0
0
0